Suchergebnisse - "Galluzzo, Marco"

PubPharm (6)

1

HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis

enthalten in: Expert opinion on biological therapy | 2021

von Morelli, M. | Galluzzo, M. | Madonna, S. | +9

2

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis

enthalten in: Expert opinion on biological therapy | 2020

von Galluzzo, M. | D'Adamio, S. | Silvaggio, D. | +3

3

Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo

enthalten in: Cell cycle (Georgetown, Tex.) | 2020

von Campione, E. | Lanna, C. | Diluvio, L. | +12

4

Secukinumab in moderate-to-severe plaque psoriasis : a multi-center, retrospective, real-life study up to 52 weeks observation

enthalten in: Expert opinion on biological therapy | 2018

von Galluzzo, M. | Talamonti, M. | De Simone, C. | +7

5

IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis

enthalten in: Dermatology (Basel, Switzerland) | 2016

von Galluzzo, M. | Boca, A. | Botti, E. | +8

6

Genetic variations in IL6 and IL12B decreasing the risk for psoriasis

enthalten in: Immunology letters | 2013

von Boca, A. | Talamonti, M. | Galluzzo, M. | +5

1
[1]